From: Accelerating diagnosis of Parkinson’s disease through risk prediction
Description | OR | FDR Adjusted P Value | PD Prevalance | non-PD Prevalance |
---|---|---|---|---|
Abnormality of gait | 8.31 | 2.80E-188 | 15.91% | 2.05% |
Abnormal involuntary movements | 55.96 | 1.49E-168 | 19.67% | 0.35% |
Malaise and fatigue | 3.53 | 2.33E-112 | 20.78% | 6.27% |
Essential tremor | 38.04 | 1.96E-79 | 8.30% | 0.23% |
Depression | 4.07 | 2.96E-76 | 10.96% | 2.94% |
Back pain | 2.53 | 2.98E-62 | 16.11% | 7.34% |
Essential hypertension | 1.57 | 3.41E-57 | 42.66% | 31.15% |
Dizziness and giddiness (Light-headedness and vertigo) | 3.08 | 2.08E-54 | 12.11% | 4.25% |
Anxiety disorder | 3.51 | 1.72E-51 | 8.51% | 2.67% |
Major depressive disorder | 4.16 | 1.73E-47 | 4.74% | 1.17% |
Pain in joint | 1.98 | 6.84E-46 | 21.10% | 12.25% |
Constipation | 3.52 | 5.03E-42 | 7.73% | 2.39% |
Spondylosis without myelopathy | 2.68 | 5.19E-40 | 11.21% | 4.13% |
Lack of coordination | 10.97 | 1.63E-39 | 4.29% | 0.37% |
Pain in limb | 2.26 | 6.99E-35 | 13.70% | 6.76% |
Extrapyramidal disease and abnormal movement disorders | 51.01 | 8.70E-35 | 4.42% | 0.09% |
Abdominal pain | 2.19 | 1.43E-33 | 12.52% | 6.34% |
Type 2 diabetes | 1.78 | 4.41E-32 | 13.33% | 8.94% |
Urinary incontinence | 3.46 | 9.38E-32 | 5.03% | 1.69% |